
- Industry news
Industry news
- Category news
- Reports
- Key trends
- Multimedia
Multimedia
- Journal
- Events
- Suppliers
Suppliers
- Home
- Industry news
Industry news
- Category news
- Reports
- Key trends
- Multimedia
Multimedia
- Events
- Suppliers
Suppliers
Boosting NAD+: Tru Niagen and US advertising board clash over supplement claims
Niagen Bioscience says it rejects the logic behind a recommendation by the US National Advertising Review Board (NARB) to remove or significantly modify advertising claims for its flagship nicotinamide riboside (NR) supplement, Tru Niagen. Although the company has agreed to comply with the board’s recommendation, it argues that the standards are restrictive and could discourage companies from communicating scientific research.Peak cardio performance: Consumers seek multifunctional active nutrition
Active nutrition is transforming from an athlete niche to the mainstream, and transitions from sports performance to everyday life. Further propelling this trend, consumers are becoming more knowledgeable about their health, and are increasingly seeking multifunctional, science-backed products. Nutrition Insight sits down with experts from Balchem Human Nutrition & Health, Gnosis by Lesaffre, and Kensing for an in-depth look into the main trends in peak performance and cardiovascular health.Global Mitochondrial Health Summit 2026: How nutraceuticals power cellular energy for longevity
Mitochondrial health is now recognized as vital for overall well-being and longevity. Leading clinicians, researchers, and educators on the emerging science behind the cellular powerhouse will be meeting on June 26 at the inaugural Global Mitochondrial Health Summit, hosted by Kaneka Ubiquinol.Ahead of the event in Sydney, Australia, Nutrition Insight speaks with Dr. Kazunori Hosoe, scientist and researcher at Kaneka Corporation, about advancements in mitochondrial science, gaps in nutraceutical products, and how the industry can communicate complex science with consumer-friendly messaging.Mycondro™ The non‑animal chondroitin engineered for motion non-Animal, fermentation-Driven, superior-quality chondroitin sulfate
Mobility transcends age, it's about freedom, performance, prevention, and lasting vitality. From athletes and active adults to physically taxed professionals and seniors determined to stay independent, this White Paper reveals how MyCondro™ revolutionizes movement with a real, transformative innovation.This Technical Paper is brought to you by Gnosis by Lesaffre.
Vitafoods Europe 2026: Arla Foods Ingredients’ protein innovations for GLP-1 support
Peter Andersen, the senior director at Arla Foods Ingredients, spoke about how GLP-1 users lose up to 40% of weight from lean muscle and how this is driving demand for compact, high-quality protein solutions. Andersen also covered the company’s gut health partnership with Novonesis and introduced the company’s lighter-textured “air bar” protein format.Vitafoods Europe 2026 review
The nutrition industry highlighted its latest innovations and scientific advances at this year’s Vitafoods Europe (May 5–7) in Barcelona, Spain. Longevity, women’s health, metabolic health beyond weight loss, hydration, and nutricosmetics stood out as key trends driving research and product development in the industry. Companies also presented sensory-driven delivery formats beyond pills and capsules for consumers who seek flavorful solutions that combine efficacy with convenience. Settings
- Play Interval
- Slide Duration
- Thumbnail Bar Position
Latest headlines
View more
Highlighted features

Gut health champions May 2026
Multimedia
View more
Vitafoods Europe 2026: Arla Foods Ingredients’ protein innovations for GLP-1 support
Peter Andersen, the senior director at Arla Foods Ingredients, spoke about how GLP-1 users lose up to 40% of weight from lean muscle and how this is driving demand for compact, high-quality protein solutions. Andersen also covered the company’s gut health partnership with Novonesis and...
Subscribe to our newsletters
By continuing to browse our site you agree to our Privacy Statement
































